Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Grifols Pref | Madrid | Healthcare | Pharmaceuticals | €6.18B | 43.3x | 0.01 | €7.90 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 40.1% Upside | Upgrade to Pro+ | |
Grifols | Madrid | Healthcare | Pharmaceuticals | €6.18B | 43.3x | 0.01 | €9.93 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Laborat.Rovi | Madrid | Healthcare | Pharmaceuticals | €3.89B | 26.8x | -1.39 | €76 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.3% Upside | Upgrade to Pro+ | |
Almirall | Madrid | Healthcare | Pharmaceuticals | €1.94B | -51.3x | 0.21 | €9.09 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.8% Upside | Upgrade to Pro+ | |
Pharma Mar | Madrid | Healthcare | Pharmaceuticals | €1.22B | -701x | 4.46 | €69.25 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -22.5% Downside | Upgrade to Pro+ | |
Faes Farma | Madrid | Healthcare | Pharmaceuticals | €1.14B | 11.8x | 1.58 | €3.69 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.3% Upside | Upgrade to Pro+ | |
Clinica Baviera | Madrid | Healthcare | Healthcare Providers & Services | €630.90M | 16.4x | 0.69 | €38.70 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Natac Natural Ingredients | Madrid | Healthcare | Pharmaceuticals | €273.93M | -39.2x | €0.63 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Atrys Health | Madrid | Healthcare | Healthcare Providers & Services | €255.91M | -6.6x | -0.76 | €3.41 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Laboratorio Reig Jofre | Madrid | Healthcare | Pharmaceuticals | €250.59M | 26.4x | -12.34 | €3.11 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31% Upside | Upgrade to Pro+ | |
Prim | Madrid | Healthcare | Healthcare Equipment & Supplies | €169.14M | 14.8x | 0.89 | €9.94 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oryzon Genomics | Madrid | Healthcare | Biotechnology & Medical Research | €113.04M | -29.5x | €1.80 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Pangaea Oncology | Madrid | Healthcare | Biotechnology & Medical Research | €60.98M | -11.6x | 0.18 | €1.79 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biotechnology Assets | Madrid | Healthcare | Biotechnology & Medical Research | €19.01M | 11.1x | 0.07 | €0.30 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Labiana Health | Madrid | Healthcare | Pharmaceuticals | €17.51M | -3.9x | €2.48 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -3.2% Downside | Upgrade to Pro+ | ||
Substrate Artificial Inteligence | Madrid | Healthcare | Healthcare Equipment & Supplies | €9.26M | -1x | -0.01 | €0.10 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Euroespes S.A. | Madrid | Healthcare | Healthcare Providers & Services | €3.67M | -3.2x | €0.34 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |